Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|10|7|1433-1436

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.10, Iss.7, 2012-07, pp. : 1433-1436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivaroxaban, a new oral factor Xa inhibitor, provides new data on anticoagulation

By Siddique Aurangzeb   Lip Gregory YH   Shantsila Eduard  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 187-189

Future Medicine

Access to resources Recommend Favorite

Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1435-1436

John Wiley & Sons Inc

Access to resources Recommend Favorite

REPORT OF THE SENATE SUBCOMMITTEE ON PROBLEMS OF THE AGED AND AGING

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 8, Iss. 6, 1960-06 ,pp. : 495-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative Study of a Portable Monitor for Prothrombin Time Determination, Coaguchek®, with Three Systems for Control of Oral Anticoagulant Treatment

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 6, 1999-08 ,pp. : 321-328

Karger

Access to resources Recommend Favorite

Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 2, 2018-02 ,pp. : 280-291

John Wiley & Sons Inc

Access to resources Recommend Favorite